Pan-cancer analyses have revealed that FOXM1 overexpression is widespread in human cancer and is linked to reduced patient survival and genomic instability (Jiang et al., 2015; Li et al., 2017a; Barger et al., 2019; Gentles et al., 2015; Carter et al., 2006). The gene discussed is FOXM1; the disease is cancer.